echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Notice on Publicly Soliciting Opinions on the "Guiding Principles for the Expansion of Cohort Research in the First Human Trial of Antitumor Drugs (Draft for Solicitation of Comments)"

    Notice on Publicly Soliciting Opinions on the "Guiding Principles for the Expansion of Cohort Research in the First Human Trial of Antitumor Drugs (Draft for Solicitation of Comments)"

    • Last Update: 2021-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Anti-tumor drugs are a hot spot in the research and development of innovative drugs in the world.


    The time limit for soliciting opinions is 30 days from the date of publication


    Please send your feedback to the mailbox of the following contact:

    Contact: Wang Yuzhu, Gao Lili

    Contact: wangyzh@cde.


    Thank you for your participation and great support


    Drug Evaluation Center of the State Drug Administration

    August 3, 2021

    Attachment 1: "Technical Guidelines for the Expansion of Cohort Studies in the First Human Trials of Antitumor Drugs (Draft for Comment)".


    "Guiding Principles for the Expansion of Cohort Studies in the First Human Trial of Antitumor Drugs (Draft for Comment)".


    Drafting Instructions for "Expanded Cohort Study Technical Guidelines for the First Human Trial of Antitumor Drugs (Draft for Comment)".


    "Guiding Principles for the Expansion of Cohort Studies in the First Human Trial of Antitumor Drugs (Draft for Comment)" feedback form.
    docx
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.